A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer

1. Glisson, B.
2. Besse, B.
3. Dols, M.C.
4. Dubey, S.
5. Schupp, M.
6. Jain, R.
7. Jiang, Y.
8. Menon, H.
9. Nackaerts, K.
10. Orlov, S.
11. Paz-Ares, L.
12. Ramlau, R.
13. Tang, R.
14. Zhang, Y.
15. Zhu, M.